JEFFREY SHERER

Concepts (76)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bipolar Disorder
4
2019
346
0.410
Why?
Antipsychotic Agents
4
2017
375
0.340
Why?
Antidepressive Agents
3
2017
287
0.310
Why?
Psychotropic Drugs
2
2019
124
0.280
Why?
Diphosphonates
1
2007
37
0.280
Why?
Refuse Disposal
1
2006
5
0.260
Why?
Imidazoles
1
2007
199
0.250
Why?
Dementia
3
2021
448
0.250
Why?
Environmental Pollutants
1
2006
68
0.250
Why?
Drug Prescriptions
2
2017
217
0.230
Why?
Environmental Exposure
1
2006
217
0.220
Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
255
0.210
Why?
Bone Neoplasms
1
2007
427
0.200
Why?
Urinary Bladder, Overactive
1
2021
28
0.190
Why?
Medication Adherence
2
2015
388
0.170
Why?
Weight Gain
2
2019
401
0.160
Why?
Nursing Homes
2
2010
95
0.160
Why?
Prostatic Neoplasms
1
2007
1515
0.150
Why?
Atomoxetine Hydrochloride
1
2017
15
0.140
Why?
Child Psychiatry
1
2017
17
0.140
Why?
Adrenergic Uptake Inhibitors
1
2017
27
0.140
Why?
Central Nervous System Stimulants
1
2017
125
0.130
Why?
Physicians, Primary Care
1
2017
94
0.130
Why?
Nebulizers and Vaporizers
1
2015
57
0.120
Why?
Body Mass Index
2
2019
1541
0.120
Why?
Attention Deficit Disorder with Hyperactivity
1
2017
216
0.110
Why?
Patient Readmission
1
2015
366
0.100
Why?
Patient Discharge
1
2015
485
0.090
Why?
Practice Patterns, Physicians'
1
2017
711
0.090
Why?
Homes for the Aged
1
2010
24
0.090
Why?
Cholinergic Antagonists
1
2010
51
0.090
Why?
United States
7
2021
10631
0.090
Why?
Computers, Handheld
1
2009
33
0.080
Why?
Pharmacists
1
2009
83
0.080
Why?
Drug Utilization Review
1
2009
33
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2015
596
0.080
Why?
Health Care Surveys
1
2009
284
0.070
Why?
United States Environmental Protection Agency
1
2006
7
0.070
Why?
Retrospective Studies
5
2021
16021
0.060
Why?
Male
11
2021
60082
0.060
Why?
United States Food and Drug Administration
1
2006
148
0.060
Why?
Aged
6
2021
19080
0.060
Why?
Pharmaceutical Preparations
1
2006
80
0.060
Why?
Aged, 80 and over
3
2010
6371
0.050
Why?
Cohort Studies
2
2014
4705
0.050
Why?
Galantamine
1
2021
10
0.050
Why?
Rivastigmine
1
2021
17
0.050
Why?
Female
10
2021
65489
0.050
Why?
Humans
12
2021
123163
0.050
Why?
Muscarinic Antagonists
1
2021
38
0.050
Why?
Adolescent
5
2019
19102
0.050
Why?
Medicaid
2
2014
245
0.050
Why?
Cholinesterase Inhibitors
1
2021
90
0.050
Why?
Child
5
2019
24234
0.040
Why?
Withholding Treatment
1
2019
67
0.040
Why?
Medicare
1
2021
424
0.040
Why?
Antineoplastic Agents
1
2007
1661
0.040
Why?
Middle Aged
3
2015
25992
0.030
Why?
Body Weight
1
2019
1001
0.030
Why?
Bronchodilator Agents
1
2015
153
0.030
Why?
Risk
1
2014
747
0.030
Why?
Cross-Sectional Studies
2
2010
3378
0.020
Why?
Treatment Outcome
1
2007
12129
0.020
Why?
Proportional Hazards Models
1
2014
1305
0.020
Why?
Prescriptions
1
2009
39
0.020
Why?
Regression Analysis
1
2009
771
0.020
Why?
Psychotic Disorders
1
2009
140
0.020
Why?
Time Factors
1
2017
6217
0.020
Why?
Activities of Daily Living
1
2009
405
0.020
Why?
Follow-Up Studies
1
2014
5046
0.020
Why?
Predictive Value of Tests
1
2010
2106
0.020
Why?
Sex Factors
1
2009
1259
0.020
Why?
Prevalence
1
2010
2404
0.010
Why?
Anxiety
1
2009
952
0.010
Why?
Prospective Studies
1
2009
6032
0.010
Why?
Adult
1
2009
29057
0.010
Why?
SHERER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (76)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_